Table of Contents
What changed
Investment income (reported as revenue) fell 62.4% to NZ$12.5m, dragging PBT down 70.8% to NZ$8.5m and NPAT down 71.9% to NZ$7.9m. Operating cash flow swung from a NZ$11.3m inflow to a NZ$0.5m outflow. Despite the P&L weakness, the balance sheet strengthened: cash rose to NZ$22.0m from NZ$5.8m, borrowings remained nil, and total equity increased 11.5% to NZ$240.6m — a NZ$24.8m equity uplift that is materially larger than FY25 NPAT, implying a capital-raising or reinvestment contribution outside reported earnings. The final dividend was cut 7.8% to 1.41cps.
What matters
- Second half was loss-making. HY25 NPAT was NZ$8.9m, already 113% of the FY25 figure, implying an H2 NPAT of roughly –NZ$1.0m on only NZ$1.2m of H2 revenue (9.4% of the full-year revenue). The full-year headline understates how poor the second half was.
- Dividend cover deteriorated sharply. Payout against NPAT rose to 56.6% from 15.2%, and ROE fell to 3.3% from 13.0%. The dividend was trimmed, but far less than earnings fell.
- Cash conversion broke down. Operating cash flow moved NZ$11.8m adversely year-on-year into net outflow territory, even though headline profit was still positive.
Expectations
No stated targets, forward-work book, or guidance were disclosed, and as a listed investment vehicle the result is inherently driven by mark-to-market portfolio movements rather than a repeatable revenue run-rate. The HY25/FY25 shape is the only forward signal available and it is negative: H2 revenue of NZ$1.2m and an H2 NPAT loss mean the exit trajectory into FY26 is materially weaker than the full-year averages suggest.
Quality of result
Earnings quality is low on two fronts. First, the result is tax-distorted — the effective tax rate was 6.6% (FY24: 3.1%), well below a statutory rate, so PBT (–70.8%) is the cleaner read than NPAT (–71.9%). Second, the NZ$7.9m profit was not backed by cash: operating activities produced a NZ$0.5m outflow, versus an NZ$11.3m inflow in FY24, meaning much of the profit is unrealised fair-value movement rather than realised cash income. Balance-sheet direction is the genuinely durable positive: cash quadrupled, gearing remained zero, and equity rose, but much of that appears to reflect capital inflows rather than earnings retention.
Unresolved
- What drove the H2 reversal — was it specific portfolio holdings, sector exposure, or broader market mark-downs?
- The NZ$24.8m equity increase exceeds NZ$7.9m NPAT by roughly NZ$17m; the release extract does not make the source (share issuance, DRP, other comprehensive income) explicit.
- With payout at 56.6% of NPAT and operating cash flow negative, how is the dividend being funded going forward?
- No capex, free cash flow, NTA per share, or portfolio concentration detail is disclosed in the extracted material.
This briefing cannot assess portfolio composition, underlying holding-level performance, or NTA-to-price valuation, none of which were provided in the extraction.
Key metrics
| Metric | FY25 | FY24 | Change |
|---|---|---|---|
| Revenue | $12.5m | $33.1m | -62.4% ↓ |
| Net profit after tax | $7911m | $28112m | -71.9% ↓ |
| Net cash inflow from operating activities | −$509m | $11298m | -104.5% ↓ |
| Final dividend per share | 1.4c | 1.5c | -7.8% ↓ |
| Profit before tax | $8465m | $29015m | -70.8% ↓ |
| Cash and cash equivalents | $22.0m | $5.8m | +280.7% ↑ |
| Total assets | $241.7m | $218.7m | +10.5% ↑ |
Reference: annolyse.ai/briefings/brm-fy25
Analytical metrics
| Metric | FY25 | FY24 | Context |
|---|---|---|---|
| PBT growth | -70.8% | — | cleaner earnings measure |
| Effective tax rate | 6.5% | 3.1% | — |
| Net debt | −$22.0m | −$5.8m | −$16.2m |
| Gross borrowings | $0.0m | — | — |
| Payout ratio vs NPAT | 56.6% | — | — |
| ROE (annualised) | 3.3% | 13.0% | Weakening |
| HY25 share of FY25 revenue | 90.6% | — | Other half was 9.4% |
| HY25 share of FY25 NPAT | 113.0% | — | Other half was -13.0% |
| Profit from continuing operations | $7911.0m | $28.1m | +$7882.9m |
Reference: annolyse.ai/briefings/brm-fy25
This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.